Qorvo/ US74736K1016 /
9/29/2023 9:59:56 PM | Chg. 0.00 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
95.49USD | 0.00% | 22,985 Turnover: 2.2 mill. |
-Bid Size: - | -Ask Size: - | 10.45 bill.USD | 0.00% | 10.11 |
GlobeNewswire
2/28/2022
Qorvo® to Present at the Raymond James 43rd Annual Institutional Investors Conference
GlobeNewswire
2/7/2022
Qorvo Biotechnologies Awarded $4.1 Million National Institutes of Health Contract for SARS-CoV-2/ Fl...
GlobeNewswire
1/6/2022
Qorvo® Simplifies Wi-Fi 6E System Design with the First Single FEM to Support 5.1 to 7.1 GHz Bands
GlobeNewswire
12/1/2021
Qorvo® to Present at Barclays Global Technology, Media and Telecommunications Virtual Conference
GlobeNewswire
11/10/2021
Qorvo® Biotechnologies Omnia™ SARS-CoV-2 Antigen Test Detects Delta and Other Circulating Variants i...
GlobeNewswire
11/3/2021
Qorvo® Acquires United Silicon Carbide (UnitedSiC), a Leading Provider of Silicon Carbide Power Semi...
GlobeNewswire
11/3/2021
Qorvo® Announces Appointment of Philip Chesley as President of Infrastructure & Defense Products
GlobeNewswire
7/28/2021
Qorvo Biotechnologies Omnia™ SARS-CoV-2 Antigen Test Platform Validated in National Institutes of He...
GlobeNewswire
6/21/2021
Qorvo Advances Radar Architecture with Reconfigurable Dual-band GaN Power Amplifier MMICs
GlobeNewswire
6/7/2021
Qorvo® Solutions Interoperable with Apple* U1 Chip for New Ultra-Wideband Enabled Experiences
GlobeNewswire
6/1/2021
Qorvo® to Present at the Bank of America Securities 2021 Global Technology Conference